BPG is committed to discovery and dissemination of knowledge
Articles in Press
2/6/2026 12:06:06 PM | Browse: 2 | Download: 0
| Category |
Virology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Respiratory syncytial virus in cirrhosis: Time to separate data from dogma?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Jorge Quarleri and María Victoria Delpino |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jorge Quarleri, PhD, Principal Investigator, Professor, Senior Researcher, Tenured Professor, Instituto de Investigaciones Biomédicas en Retrovirus y Sida, Universidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas, Paraguay 2155, Buenos Aires C1121ABG, Argentina. quarleri@fmed.uba.ar |
| Key Words |
Respiratory syncytial virus; Cirrhosis; Vaccine; Influenza virus; SARS-CoV-2; COVID-19 |
| Core Tip |
Although cirrhosis is frequently categorized as a high-risk condition for adult respiratory syncytial virus (RSV) infection, direct evidence supporting this classification remains limited. Recent real-world data indicate that RSV-related hospitalizations among patients with cirrhosis are uncommon and not independently associated with increased mortality, in contrast to the well-established risk observed in cardiopulmonary and renal diseases. Consequently, current RSV vaccination recommendations for individuals with cirrhosis rely largely on extrapolation rather than robust cirrhosis-specific evidence. Until stronger data become available, RSV vaccination in cirrhosis should be individualized, taking into account age and co-morbidities, while prioritizing multicenter studies to better define true risk and clinical benefit. |
| Citation |
Quarleri J, Delpino MV. Respiratory syncytial virus in cirrhosis: Time to separate data from dogma? World J Hepatol 2026; In press |
 |
Received |
|
2026-01-08 06:41 |
 |
Peer-Review Started |
|
2026-01-08 06:41 |
 |
First Decision by Editorial Office Director |
|
2026-01-16 06:48 |
 |
Return for Revision |
|
2026-01-16 06:48 |
 |
Revised |
|
2026-01-16 18:38 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2026-02-06 02:48 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-02-06 12:06 |
 |
Articles in Press |
|
2026-02-06 12:06 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345